SCHEMBL10786191

SCHEMBL10786191

O=C(O)c1cc(C(F)(F)F)ccc1O.[NaH]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
HPGD P15428 4/20 0.58
KDM4E B2RXH2 3/20 0.58
HSD17B10 Q99714 3/20 0.58
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
PTGS2 P35354 2/20 0.53
CA12 O43570 1/20 0.53
ALOX5 P09917 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
CES2 O00748 2/20 0.52
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
CYP2C19 P33261 2/20 0.50
KDR P35968 2/20 0.50
USP2 O75604 1/20 0.50
TNF P01375 1/20 0.50
CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL130628 0.98 ALDH1A1 (0.59) ALDH1A1HPGDKDM4EHSD17B10CA1
SCHEMBL27866247 0.85 ALDH1A1 (0.62) ALDH1A1HPGDKDM4EHSD17B10CA1
SCHEMBL330660 0.84 ACMSD (0.66) ALDH1A1HPGDKDM4EHSD17B10CA1
SCHEMBL131207 0.83 CA1 (0.52) ALDH1A1HPGDKDM4EHSD17B10CA1
SCHEMBL115659 0.82 ALDH1A1 (0.65) ALDH1A1HPGDKDM4EHSD17B10CA1
SCHEMBL460066 0.82 KDM4E (0.69) ALDH1A1HPGDKDM4EHSD17B10CES2
SCHEMBL8949395 0.81 CA1 (0.50) ALDH1A1HPGDKDM4EHSD17B10CA1
SCHEMBL10455841 0.81 CES2 (0.52) ALDH1A1HPGDKDM4EHSD17B10CES2
SCHEMBL320481 0.81 CES2 (0.52) ALDH1A1HPGDKDM4EHSD17B10CES2
SCHEMBL30062195 0.81 CES2 (0.52) ALDH1A1HPGDKDM4EHSD17B10CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0036534-B1 AN ORALLY ADMINISTRABLE DRUG FORM COMPRISING A BETA-LACTAM ANTIBIOTIC AND AN ADJUVANT INTERx RESEARCH CORPORATION (US) 1987-09-23 EP disclosed
EP-0035770-B1 AN ORALLY ADMINISTERED DRUG FORM COMPRISING A GLYCOSIDIC ANTIBIOTIC AND AN ADJUVANT INTERx RESEARCH CORPORATION (US) 1986-12-30 EP disclosed
EP-0036145-B1 AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT INTERx RESEARCH CORPORATION (US) 1985-05-29 EP disclosed
EP-0031561-B1 A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT MERCK & CO. INC. (US) 1985-04-10 EP disclosed
US-4470980-A Method of increasing oral absorption of β-lactam antibiotics INTERX RESEARCH CORP. (US) 1984-09-11 US disclosed
US-4464363-A HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS MERCK & CO., INC. (US) 1984-08-07 US disclosed
US-4406896-A ANTIBIOTICS, ACIDS, HYDROXY MERCK & CO., INC. (US) 1983-09-27 US disclosed
EP-0036534-A1 An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-30 EP disclosed
EP-0036145-A1 An orally administered drug form comprising a polar bioactive agent and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-23 EP disclosed
EP-0035770-A2 An orally administered drug form comprising a glycosidic antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-16 EP disclosed
EP-0031561-A2 A rectally administered suppository comprising a drug and an adjuvant MERCK & CO. INC. (US) 1981-07-08 EP disclosed